| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 31002-79-6 | 苯曲安奈德; 9-氟-11b,21-二羥基-16a,17-[(1-甲基亞乙基)雙(氧)]-孕甾-1,4-二烯-3,20-二酮2-(苯甲酰胺甲基)? | Triamcinolone benetonide; Pregna-1,4-diene-3,20-dione,9-fluoro-11b,16a,17,21-tetrahydroxy-, cyclic 16,17-acetal withacetone, 21-ester with N-benzoyl-2-methyl-b-alanine (8CI); TBI; Tibicorten; Triamcinoloneacetonide 21-(benzoyl-b-aminoisobutyrate); Triamcinolone acetonide 21-(b-benzamidoisobutyrate); Triamcinolone acetonide benzoyl-b-aminoisobutyrate; Triamcinolone benetonide; b-Alanine, N-benzoyl-2-methyl-, 21-ester with9-fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic16,17-acetal with acetone |  | C35H42FNO8 | 詳情 | 供應(yīng)商 |
| 40666-16-8 | 氟前列醇; (5Z)-rel-7-[(1R,2R,3R,5S)-3,5-二羥基-2-[(1E,3R)-3-羥基-4-[3-(三氟甲基)苯氧基]-1-丁烯基]環(huán)戊 | Fluprostenol; (5Z)-rel-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid |  | C23H29F3O6 | 詳情 | 供應(yīng)商 |
| 87771-40-2 | 碘氟醇; 碘佛醇; N,N'-雙(2,3-二羥基丙基)-5-[(2-羥基乙�；�)-(2-羥乙基)氨基]-2,4,6-三碘苯-1,3-二甲酰胺 | Ioversol; N,N'-Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide |  | C18H24I3N3O9 | 詳情 | 供應(yīng)商 |
| 93957-53-0 | 氟伐他汀甲酯; (3R,5S,6E)-7-[3-(4-氟苯基)-1-(1-甲基乙基)-1-氫-吲哚-2-基]-3,5-二羥基庚-6-烯酸甲酯 | Fluvastatin methyl ester; Methyl (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoate |  | C25H28FNO4 | 詳情 | 供應(yīng)商 |
| 93957-54-1 | 氟伐他汀; 7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羥基-6-庚烯酸 | Fluvastatin; 7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid |  | C24H26FNO4 | 詳情 | 供應(yīng)商 |
| 93957-55-2 | 氟伐他汀鈉; [R*,S*-(E)]-(+/-)-7-[3-(4-氟苯基)-1-(1-甲基乙基)-1-氫-吲哚-2-基]-3,5-二羥基庚-6-烯酸鈉 | Fluvastatin sodium salt; Sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoate |  | C24H25FNNaO4 | 詳情 | 供應(yīng)商 |
| 110862-48-1 | 阿伐他汀; 阿托伐他汀; (3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲酰基)-5-異丙基吡咯-1-基]-3,5-二羥基? | Atorvastatin; (3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid |  | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
| 129332-29-2 | 氟伐二醇; (E)-7-[3'-(4''-氟苯基)-1'-異丙基吲哚-2'-基]-3,5-二羥基-6-庚烯酸叔丁酯 | tert-Butyl (E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-methylethyl-indol-2'-yl]-6-heptenoate; 6-Heptenoicacid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,1,1-dimethylethyl ester, [R*,S*-(E)]-(?à)-; 6-Heptenoic acid,7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,1,1-dimethylethyl ester, [R*,S*-(E)]- |  | C28H34FNO4 | 詳情 | 供應(yīng)商 |
| 134523-00-5 | 阿伐他汀; 阿托伐他汀; (3R,5R)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲�；�)-5-異丙基-吡咯-1-基]-3,5-二羥基 | Atorvastatin; (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid |  | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
| 134523-03-8 | 阿托伐他汀鈣; 7-[2-(4-氟苯基)-3-苯基-4-(苯胺基甲�；�)-5-(2-丙基)吡咯-1-基]-3,5-二羥基庚酸鈣 | Atorvastatin calcium; Lipitor; [R-(R*, R*)]-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1H-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt |  | (C33H34FN2O5)2.Ca;C66H68CaF2N4O10 | 詳情 | 供應(yīng)商 |
| 143201-11-0 | 西立伐他汀鈉; (+)-(3R,5S,6E)-7-[4-(4-氟苯基)-2,6-二異丙基-5-甲氧甲基-吡啶-3-基]-3,5-二羥基-6-庚烯酸單 | Cerivastatin sodium; Sodium 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate |  | C26H33FNNaO5 | 詳情 | 供應(yīng)商 |
| 147511-69-1 | 匹伐他汀; (3R,5S,6E)-7-(2-環(huán)丙基-4-(4-氟苯基)喹啉-3-基)-3,5-二羥基庚-6-烯酸 | Pitavastatin; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid |  | C25H24FNO4 | 詳情 | 供應(yīng)商 |
| 147526-32-7 | 匹伐他汀鈣; (+)-雙{(3R,5S,6E)-7-[2-環(huán)丙基-4-(4-氟代苯基)喹啉-3-基]-3,5-二羥基-6-庚烯酸}鈣鹽(2:1) | Pitavastatin calcium; ：(+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate} |  | C50H46CaF2N2O8 | 詳情 | 供應(yīng)商 |
| 157283-68-6 | 曲沃前列素; (E)-7-[(1R,2S,3R,5S)-3,5-二羥基-2-[(E)-3-羥基-4-[3-(三氟甲基)苯氧基]丁-1-烯基]環(huán)戊基]庚-5 | Travoprost; Propan-2-yl (E)-7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate |  | C26H35F3O6 | 詳情 | 供應(yīng)商 |
| 172336-32-2 | (E)-3,5-二羥基-7-[2-環(huán)丙基-4-(4-氟苯基)-3-喹啉基]庚-6-烯酸乙酯 | Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate; (3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester |  | C27H28FNO4 | 詳情 | 供應(yīng)商 |
| 194934-96-8 | 氟伐他汀中間體; (E)-3,5-二羥基-7-[3'-(4''-氟苯基)-1'-(1''-甲基乙基)吲哚-2'-基]-6-庚烯酸叔丁酯 | -; 6-Heptenoicacid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,1,1-dimethylethyl ester, [S-[R*,S*-(E)]]- |  | C28H34FNO4 | 詳情 | 供應(yīng)商 |
| 209860-87-7 | 他氟前列素; (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-二氟-4-苯氧基-1-丁烯-1-基]-3,5-二羥基環(huán)戊基]-5-庚烯酸異 | Tafluprost; (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid 1-methylethyl ester |  | C25H34F2O5 | 詳情 | 供應(yīng)商 |
| 252260-02-9 | 潑斯唑來(lái); (5R)-3-[4-[1-[(2S)-2,3-二羥基-1-氧代丙基]-1,2,3,6-四氫-4-吡啶基]-3,5-二氟苯基]-5-[(3-異惡唑 | Posizolid; (5R)-3-[4-[1-[(2S)-2,3-Dihydroxy-1-oxopropyl]-1,2,3,6-tetrahydro-4-pyridinyl]-3,5-difluorophenyl]-5-[(3-isoxazolyloxy)methyl]-2-oxazolidinone |  | C21H21F2N3O7 | 詳情 | 供應(yīng)商 |
| 287714-41-4 | 羅伐他汀; 羅素他汀; 羅蘇伐他汀; 7-[4-(4-氟苯基)-6-異丙基-2-(甲基-甲磺酰-氨基)-嘧啶-5-基]-3,5-二羥基庚-6 | Rosuvastatin; 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid |  | C22H28FN3O6S | 詳情 | 供應(yīng)商 |
| 355806-00-7 | 瑞舒伐他汀叔丁酯; (6E)-7-[4-(4-氟苯基)-6-異丙基-2-[甲基(甲磺酰)氨基]嘧啶-5-基]-(3R,5S)-3,5-二羥基庚-6 | tert-Butyl rosuvastatin; tert-Butyl (6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl)me |  | C26H36FN3O6S | 詳情 | 供應(yīng)商 |